(Q50629201)

English

Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: Primary and metastatic melanoma and halo and giant pigmented nevi

scientific article published on November 1, 1975

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081937

20 August 2022

Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: Primary and metastatic melanoma and halo and giant pigmented nevi (English)

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

metastatic melanoma

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

author name string

R. L. Edelson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081937

20 August 2022

V. J. Hearing

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081937

20 August 2022

A. L. Dellon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081937

20 August 2022

M. Frank

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081937

20 August 2022

E. K. Edelson

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081937

20 August 2022

I. Green

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081937

20 August 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1081937

20 August 2022

publication date

1 November 1975

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

full work available at URL

https://api.elsevier.com/content/article/PII:0090122975900975?httpAccept=text/xml

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

https://api.elsevier.com/content/article/PII:0090122975900975?httpAccept=text/plain

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Clinical Immunology and Immunopathology

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

4

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

4

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

557-568

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

Histopathological diagnosis of malignant melanoma

2

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells

8

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Cytophilic Antibodies in Man

9

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Identification of Subpopulations of Mononuclear Cells in Cutaneous Infiltrates I. Differentiation Between B Cells, T Cells, and Histiocytes

11

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

The classification of malignant melanoma and its histologic reporting

12

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies

13

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Lymphocytes and the immune response. I.

15

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

18

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Halo nevi and melanoma

20

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

GIANT PIGMENTED NEVI, MELANOMA, AND LEPTOMENINGEAL MELANOCYTOSIS: A CLINICAL AND HISTOPATHOLOGICAL STUDY

22

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Malignant transformation in giant congenital pigmented nevus. Death in early childhood

23

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

The risk of malignancy in large congenital nevi

24

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Demonstration of cell-mediated immunity to human neoplasms of various histological types

25

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Cellular and humoral immunity against human malignant melanoma

26

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Evidence for tumor-specific immunity in human malignant melanoma

28

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Cytotoxic lymphocytes in melanoma patients

29

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Cell-mediated immunity in patients with malignant melanoma

30

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

34

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Elution of “blocking factors” from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes

37

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen

38

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.

39

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

41

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other Diseases

47

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Synergy among lymphoid cells mediating the graft-versus-host response. IV. Synergy in the GVH reaction quantitated by a mortality assay in sublethally irradiated recipients

49

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages

51

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies

55

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS

56

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Cytotoxic effects of lymphoid cells in vitro

57

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker

61

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?

62

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.

63

1 reference

10.1016/0090-1229(75)90097-5

https://api.crossref.org/works/10.1016/0090-1229(75)90097-5

4 September 2023

Identifiers

10.1016/0090-1229(75)90097-5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

release_mv3nmvlvy5ao5mao5wbs7dbwqy

1 reference

https://api.fatcat.wiki/v0/release/mv3nmvlvy5ao5mao5wbs7dbwqy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/1081937

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50629201&oldid=1968028843"